NeoGenomics, Inc. announced that as part of the on-going restructuring efforts, the executive position of President, Advanced Diagnostics is being eliminated and as a result, Vishal Sikri, the current President, Advanced Diagnostics, will no longer hold such role and will no longer be a named executive officer. The effective date of the change is still being determined by the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.96 USD | +0.29% | -0.50% | -13.72% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.72% | 1.78B | |
-18.49% | 8.35B | |
+45.10% | 3.58B | |
-8.06% | 2.47B | |
-38.71% | 2.46B | |
-7.96% | 2.36B | |
-19.73% | 1.53B | |
-40.78% | 1.21B | |
+8.32% | 1.12B | |
-11.35% | 1.09B |
- Stock Market
- Equities
- NEO Stock
- News NeoGenomics, Inc.
- NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics